Sponsored Education
Jun 24, 2025 - Jun 24, 2025
Newly Approved Treatment in Alzheimer’s Disease
Join us for a live webinar June 24 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1